These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


939 related items for PubMed ID: 26345808

  • 21. MiR-373 targeting of the Rab22a oncogene suppresses tumor invasion and metastasis in ovarian cancer.
    Zhang Y, Zhao FJ, Chen LL, Wang LQ, Nephew KP, Wu YL, Zhang S.
    Oncotarget; 2014 Dec 15; 5(23):12291-303. PubMed ID: 25460499
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein.
    Ying X, Wei K, Lin Z, Cui Y, Ding J, Chen Y, Xu B.
    Cell Physiol Biochem; 2016 Dec 15; 39(2):501-10. PubMed ID: 27383536
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The role of miR-205 in the VEGF-mediated promotion of human ovarian cancer cell invasion.
    Li J, Li L, Li Z, Gong G, Chen P, Liu H, Wang J, Liu Y, Wu X.
    Gynecol Oncol; 2015 Apr 15; 137(1):125-33. PubMed ID: 25597268
    [Abstract] [Full Text] [Related]

  • 27. miR-146a Inhibits Proliferation and Enhances Chemosensitivity in Epithelial Ovarian Cancer via Reduction of SOD2.
    Cui Y, She K, Tian D, Zhang P, Xin X.
    Oncol Res; 2016 Apr 15; 23(6):275-82. PubMed ID: 27131313
    [Abstract] [Full Text] [Related]

  • 28. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival.
    Fu X, Li Y, Alvero A, Li J, Wu Q, Xiao Q, Peng Y, Hu Y, Li X, Yan W, Guo K, Zhou W, Wang Y, Liu J, Zhang Y, Mor G, Wen J, Yin G.
    Oncotarget; 2016 Dec 06; 7(49):80633-80654. PubMed ID: 27811362
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.
    Peng DX, Luo M, Qiu LW, He YL, Wang XF.
    Oncol Rep; 2012 Apr 06; 27(4):1238-44. PubMed ID: 22246341
    [Abstract] [Full Text] [Related]

  • 39. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
    Zhu X, Shen H, Yin X, Long L, Chen X, Feng F, Liu Y, Zhao P, Xu Y, Li M, Xu W, Li Y.
    Oncotarget; 2017 Jun 13; 8(24):39154-39166. PubMed ID: 28388577
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 47.